Clinical Trial Update: A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial of diazoxide choline in Prader-Willi Syndrome completed; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• diazoxide choline (diazoxide choline)

Snippet

Sponsor: Soleno Therapeutics, Inc. | Conditions: Prader-Willi Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2023-09-21